Hypertension Clinical Trial
Official title:
Shandong and Ministry of Health Action on Salt and Hypertension Project (SMASH)
This final evaluation intends to evaluate SMASH implementation outcomes and intervention effects through quantitative and qualitative assessment, and provide evidence for the national government to develop salt-reduction and blood-pressure lowering strategies in large scales.
Every year, about 1.65 million people die of excessive salt intake in the world as excessive
sodium will raise blood pressure, which further increase prevalence risks of cardiovascular
and kidney diseases. Therefore, reducing salt intake has been recognized as one of the most
cost-effective measures for health improvement. Adopting critical salt-reduction measures can
substantially reduce prevalence risks of cardiovascular and other chronic diseases. In this
sense, exploring salt-reduction strategies that are widely effective among populations is
critical for prevention and management of cardiovascular diseases.
The daily salt intake currently recommended by WHO is 5g (6g is recommended by Chinese
government). It is estimated that 2.50 million people will not die each year if the global
salt consumption is lowered to the recommended level. WHO member countries have reached an
agreement to reduce 30% of the salt intake of people across the world by 2025. However, there
are not enough study evidence and practical foundation for achieving the salt-reduction goal
among all human beings.
Shandong is a large Chinese province with 96.85 million permanent population in its 138
counties (districts) and 62,719 communities (villages or municipal neighborhood communities).
Shandong has high prevalences of cardiovascular diseases with an adult hypertensive
prevalence above the national average. According to the national nutrition survey in 2002,
Shandong consumed 12.6g salt per capita for daily cooking, much higher than the recommended
amount (6g) in Chinese dietary guidelines. Shandong and the Ministry of Health signed a
five-year cooperative agreement in 2011, Shandong-MOH Action on Salt and Hypertension
("SMASH"). The program has adopted multi-angle and multi-level intervention strategies to
reduce salt intake by people for the purpose of preventing hypertension and other diseases
related to salt.
SMASH baseline survey in 2011 studied 15,350 people aged 18-69 by regions and towns with
multi-stage cluster random sampling to investigate their blood pressures and conditions. The
survey showed that hypertensive prevalence, awareness, treatment and control rates were
23.4%, 34.5%, 27.5%, 14.9% respectively. In the baseline survey, 24-hour urine of 2,112
people was collected, and a salt intake of 13.8g per person per day was obtained in
accordance with the urinary sodium data.
Since the commencement of the program, Shandong provincial government has cooperated with
relevant departments to establish a work mechanism that is led by MOH, implemented by
professional institutes and extensively engaged by the whole society. The program team has
developed food standards and regulations and promoted salt-reduction actions in catering
entities, supermarkets and food processing enterprises for a favorable environment of the
program. The program team has prepared various publicity materials, and trained key groups
(catering workers, food manufacturers, housewives and elementary school students). Salt
consumption monitoring points and cardiovascular prevalence monitoring system have been
established.
SMASH will conclude in May 2016. In order to assess the intervention course, implementation
outcomes and intervention effects, the SMASH program office decided to organize a final
evaluation of the program in the whole province in 2016, and quantitative data collection in
June and July 2016.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT04591808 -
Efficacy and Safety of Atorvastatin + Perindopril Fixed-Dose Combination S05167 in Adult Patients With Arterial Hypertension and Dyslipidemia
|
Phase 3 | |
Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
Completed |
NCT05433233 -
Effects of Lifestyle Walking on Blood Pressure in Older Adults With Hypertension
|
N/A | |
Completed |
NCT05491642 -
A Study in Male and Female Participants (After Menopause) With Mild to Moderate High Blood Pressure to Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body and How it Moves Into, Through and Out of the Body After Taking Single and Multiple Doses
|
Phase 1 | |
Completed |
NCT03093532 -
A Hypertension Emergency Department Intervention Aimed at Decreasing Disparities
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Completed |
NCT05529147 -
The Effects of Medication Induced Blood Pressure Reduction on Cerebral Hemodynamics in Hypertensive Frail Elderly
|
||
Recruiting |
NCT05976230 -
Special Drug Use Surveillance of Entresto Tablets (Hypertension)
|
||
Recruiting |
NCT06363097 -
Urinary Uromodulin, Dietary Sodium Intake and Ambulatory Blood Pressure in Patients With Chronic Kidney Disease
|
||
Completed |
NCT06008015 -
A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1015" and Co-administration of "BR1015-1" and "BR1015-2" Under Fed Conditions in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT05387174 -
Nursing Intervention in Two Risk Factors of the Metabolic Syndrome and Quality of Life in the Climacteric Period
|
N/A | |
Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
Recruiting |
NCT05121337 -
Groceries for Black Residents of Boston to Stop Hypertension Among Adults Without Treated Hypertension
|
N/A | |
Withdrawn |
NCT04922424 -
Mechanisms and Interventions to Address Cardiovascular Risk of Gender-affirming Hormone Therapy in Trans Men
|
Phase 1 | |
Active, not recruiting |
NCT05062161 -
Sleep Duration and Blood Pressure During Sleep
|
N/A | |
Completed |
NCT05087290 -
LOnger-term Effects of COVID-19 INfection on Blood Vessels And Blood pRessure (LOCHINVAR)
|
||
Not yet recruiting |
NCT05038774 -
Educational Intervention for Hypertension Management
|
N/A | |
Completed |
NCT05621694 -
Exploring Oxytocin Response to Meditative Movement
|
N/A | |
Completed |
NCT05688917 -
Green Coffee Effect on Metabolic Syndrome
|
N/A | |
Recruiting |
NCT05575453 -
OPTIMA-BP: Empowering PaTients in MAnaging Blood Pressure
|
N/A |